Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Hepatocellular 3Hypertension, Portal 2Motor Activity 1Liver Diseases 1Liver Cirrhosis 1Hepatocellular Carcinoma with PVTT 1Gastrointestinal Neoplasms 1Breast Neoplasms 1Ascites 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Letrozole 221Capecitabine 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 132Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Portasystemic Shunt, Transjugular Intrahepatic × Clear all
NCT01849978 2016-01-14

Enhancing Exercise in Breast Cancer Survivors

Duke University

Phase NA Completed
81 enrolled
Breast

Breast Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡